08/01/2026
A New Era in Drug Targeting: Polygon Technologies Announces Patent Publication for Thyroid Targeting Using ThyroDrone™️ Technology
We are thrilled to reach a monumental milestone in our journey toward medical innovation. Polygon Technologies is proud to announce that we have officially passed the stage of patent publication for our ground-breaking invention: ThyroDrone™️ Technology.
The Breakthrough: Redefining Thyroid Targeting
For years, effective drug delivery to the thyroid has been a complex pharmacological challenge. ThyroDrone™️ represents a paradigm shift—a dual-targeting lipid-based formulation designed to deliver therapeutic agents with unprecedented precision directly to the thyroid gland.
What is ThyroDrone Technology?
ThyroDrone is a sophisticated "smart delivery" system that utilizes a dual-mechanism approach to ensure active ingredients reach their destination without systemic loss:
1. The RGDFK Targeting Motif (Active Targeting):
We utilize a specific cyclic peptide (RGDFK) that acts as a key to a lock. It binds selectively to alpha v beta 3 integrin receptors, which are overexpressed in thyroid cells, allowing the treatment to be internalized directly by the target tissue.
2. Iodine Coupling (Passive Targeting): By leveraging the thyroid’s natural affinity for iodine, our technology uses the Sodium-Iodide Symporter (NIS) mechanism to "pull" the lipid-based vesicles into the follicular cells, ensuring optimal accumulation where it’s needed most.
Why it Matters?
Our patent opens a new door for both thyroid supplements and pharmaceutical drug targeting.
By enhancing bioavailability and specificity, ThyroDrone:
✅Maximizes treatment efficacy.
✅Minimizes systemic side effects.
✅Provides a superior vehicle for multivitamins, minerals, and thyroid medications.
This achievement places Polygon Technologies among the world-class leaders in targeting delivery advancements. We aren't just following the future of medicine—we are building it.
Explore the Patent: [https://patents.google.com/patent/WO2025218872A1/en]